Fu L - Search Results

1

Dominant subtype switch in avian influenza viruses during 2016-2019 in China.

Bi Y, Li J, Li S, Fu G, Jin T, Zhang C, Yang Y, Ma Z, Tian W, Li J, Xiao S, Li L, Yin R, Zhang Y, Wang L, Qin Y, Yao Z, Meng F, Hu D, Li D, Wong G, Liu F, Lv N, Wang L, Fu L, Yang Y, Peng Y, Ma J, Sharshov K, Shestopalov A, Gulyaeva M, Gao GF, Chen J, Shi Y, Liu WJ, Chu D, Huang Y, Liu Y, Liu L, Liu W, Chen Q, Shi W. Bi Y, et al. Among authors: fu g, fu l. Nat Commun. 2020 Nov 20;11(1):5909. doi: 10.1038/s41467-020-19671-3. Nat Commun. 2020. PMID: 33219213 Free PMC article.

2

Changes in the Length of the Neuraminidase Stalk Region Impact H7N9 Virulence in Mice.

Bi Y, Xiao H, Chen Q, Wu Y, Fu L, Quan C, Wong G, Liu J, Haywood J, Liu Y, Zhou B, Yan J, Liu W, Gao GF. Bi Y, et al. Among authors: fu l. J Virol. 2015 Dec 9;90(4):2142-9. doi: 10.1128/JVI.02553-15. Print 2016 Feb 15. J Virol. 2015. PMID: 26656694 Free PMC article.

3

AtMYB12 regulates flavonoids accumulation and abiotic stress tolerance in transgenic Arabidopsis thaliana.

Wang F, Kong W, Wong G, Fu L, Peng R, Li Z, Yao Q. Wang F, et al. Among authors: fu l. Mol Genet Genomics. 2016 Aug;291(4):1545-59. doi: 10.1007/s00438-016-1203-2. Epub 2016 Mar 31. Mol Genet Genomics. 2016. PMID: 27033553

4

Structure-Based Tetravalent Zanamivir with Potent Inhibitory Activity against Drug-Resistant Influenza Viruses.

Fu L, Bi Y, Wu Y, Zhang S, Qi J, Li Y, Lu X, Zhang Z, Lv X, Yan J, Gao GF, Li X. Fu L, et al. J Med Chem. 2016 Jul 14;59(13):6303-12. doi: 10.1021/acs.jmedchem.6b00537. Epub 2016 Jul 6. J Med Chem. 2016. PMID: 27341624

5

Resistance to Mutant Group 2 Influenza Virus Neuraminidases of an Oseltamivir-Zanamivir Hybrid Inhibitor.

Wu Y, Gao F, Qi J, Bi Y, Fu L, Mohan S, Chen Y, Li X, Pinto BM, Vavricka CJ, Tien P, Gao GF. Wu Y, et al. Among authors: fu l. J Virol. 2016 Nov 14;90(23):10693-10700. doi: 10.1128/JVI.01703-16. Print 2016 Dec 1. J Virol. 2016. PMID: 27654293 Free PMC article.

6

Influenza virus matrix protein M1 interacts with SLD5 to block host cell cycle.

Zhu L, Zhao W, Lu J, Li S, Zhou K, Jiang W, Duan X, Fu L, Yu B, Cai KQ, Gao GF, Liu W, Fang M. Zhu L, et al. Among authors: fu l. Cell Microbiol. 2019 Aug;21(8):e13038. doi: 10.1111/cmi.13038. Epub 2019 May 16. Cell Microbiol. 2019. PMID: 31050118

7

Avian-to-Human Receptor-Binding Adaptation of Avian H7N9 Influenza Virus Hemagglutinin.

Xu Y, Peng R, Zhang W, Qi J, Song H, Liu S, Wang H, Wang M, Xiao H, Fu L, Fan Z, Bi Y, Yan J, Shi Y, Gao GF. Xu Y, et al. Among authors: fu l. Cell Rep. 2019 Nov 19;29(8):2217-2228.e5. doi: 10.1016/j.celrep.2019.10.047. Cell Rep. 2019. PMID: 31747596 Free article.

8

Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease.

Fu L, Ye F, Feng Y, Yu F, Wang Q, Wu Y, Zhao C, Sun H, Huang B, Niu P, Song H, Shi Y, Li X, Tan W, Qi J, Gao GF. Fu L, et al. Nat Commun. 2020 Sep 4;11(1):4417. doi: 10.1038/s41467-020-18233-x. Nat Commun. 2020. PMID: 32887884 Free PMC article.

9

Structural Basis of SARS-CoV-2 Polymerase Inhibition by Favipiravir.

Peng Q, Peng R, Yuan B, Wang M, Zhao J, Fu L, Qi J, Shi Y. Peng Q, et al. Among authors: fu l. Innovation (Camb). 2021 Feb 28;2(1):100080. doi: 10.1016/j.xinn.2021.100080. Epub 2021 Jan 18. Innovation (Camb). 2021. PMID: 33521757 Free PMC article.

10

Structural basis for the inhibition of the SARS-CoV-2 main protease by the anti-HCV drug narlaprevir.

Bai Y, Ye F, Feng Y, Liao H, Song H, Qi J, Gao GF, Tan W, Fu L, Shi Y. Bai Y, et al. Among authors: fu l. Signal Transduct Target Ther. 2021 Feb 4;6(1):51. doi: 10.1038/s41392-021-00468-9. Signal Transduct Target Ther. 2021. PMID: 33542181 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8,045 results

Search Page